Arora S, Brown ZD, Sivaraj K, Hendrickson MJ, Mazzella AJ, Chang PP, Vaduganathan M, Qamar A, Gehi AK, Pandey A, Vavalle JP. The relationship between atrial fibrillation, mitral regurgitation, and heart failure subtype: the ARIC study. J Card Fail. 2022;28:883–92.

Article  PubMed  Google Scholar 

Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039–45.

Article  CAS  PubMed  Google Scholar 

Sartipy U, Dahlström U, Fu M, Lund LH. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 2017;5:565–74.

Article  PubMed  Google Scholar 

Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400–6.

Article  CAS  PubMed  Google Scholar 

Abe Y, Akamatsu K, Ito K, Matsumura Y, Shimeno K, Naruko T, Takahashi Y, Shibata T, Yoshiyama M. Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients. Circ J. 2018;82:1451–8.

Article  PubMed  Google Scholar 

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.

Article  CAS  PubMed  Google Scholar 

Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med. 2000;109:45–51.

Article  CAS  PubMed  Google Scholar 

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–62.

Article  CAS  PubMed  Google Scholar 

Ron P, Deirdre AL, Robby N, Cees BDV, Harry JGMC, Gregory YHL. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–100.

Kato ET, Goto S, Giugliano RP. Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation. Ageing Res Rev. 2019;49:115–24.

Article  CAS  PubMed  Google Scholar 

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.

Article  PubMed  Google Scholar 

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, Investigators PA. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non inferiority trial. Lancet. 2009;374:534–42.

Article  CAS  PubMed  Google Scholar 

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75:3122–35.

Article  CAS  PubMed  Google Scholar 

Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123:417–24.

Article  PubMed  Google Scholar 

Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, Stone J Jr, Shah M, Dukkipati SR, Adler S, Nair DG, Kim J, Wazni O, Price MJ, Asch FM, Holmes DR Jr, Shipley RD, Gordon NT, Allocco DJ, Reddy VY. Primary outcome evaluation of a next-generation left atrial appendage closure device: results From the PINNACLE FLX trial. Circulation. 2021;143:1754–62.

Article  CAS  PubMed  Google Scholar 

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632.

Article  PubMed  Google Scholar 

Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307–18.

Article  PubMed  Google Scholar 

Vincent F, Redfors B, Kotinkaduwa LN, Kar S, Lim DS, Mishell JM, Whisenant BK, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Cerebrovascular events after transcatheter edge-to-edge repair and guideline-directed medical therapy in the COAPT trial. JACC Cardiovasc Interv. 2023;16:1448–59.

Article  PubMed  Google Scholar 

Ohno Y, Attizzani GF, Capodanno D, Dipasqua F, Barbanti M, Cannata S, Immé S, Ministeri M, Caggegi A, Pistritto AM, et al. Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system. JACC Cardiovasc Interv. 2014;7:1322–3.

Article  PubMed  Google Scholar 

Glatthaar A, Seizer P, Patzelt J, Langer H, Schreieck J, Gawaz M. Formation of a left atrial thrombus during percutaneous mitral valve edge-to-edge repair induced by acute reduction of mitral regurgitation. J Cardiol Cases. 2017;17:33–5.

Article  PubMed  PubMed Central  Google Scholar 

Kuwata S, Taramasso M, Zuber M, Suetsch G, Attinger-Toller A, Wicki D, Maisano F, Nietlispach F. Feasibility of concomitant MitraClip and left atrial appendage occlusion. EuroInterventio. 2017;12:1940–5.

Article  Google Scholar 

D’Amico G, Estèvez-Loureiro R, Rofastes XF, Ronco F, Nombela-Franco L, Melica B, Bedogni F, Saia F, Cruz-Gonzalez I, Tarantini G. Concomitant procedure of percutaneous mitral valve repair and left atrial appendage occlusion: a multicenter study. JACC Cardiovasc Interv. 2021;14:590–2.

Article  PubMed  Google Scholar 

Frazzetto M, Sanfilippo C, Costa G, Scandura S, Castania G, De Santis J, Sanfilippo M, Di Salvo ME, Uccello S, Rugiano G, Rizzo S, Barbera C, Tamburino C, Barbanti M, Grasso C. Safety and effectiveness of concomitant mitral transcatheter edge-to-edge repair and left atrial appendage closure. J Clin Med. 2023;12:4742.

Article  PubMed  PubMed Central  Google Scholar 

Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, Naito S, Yamane T, Kimura M, Shiga T, et al. JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. Circ J. 2022;86:337–63.

Article  PubMed  Google Scholar 

Ono K, Iwasaki Y, Shimizu W, Akao M, Ikeda T, Ishii K, Inden Y, Kusano K, Kobayashi Y, Koretsune Y. JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias. Circ J. 2022;86:1790–924.

Article  CAS  PubMed  Google Scholar 

Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS. Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure. JACC Cardiovasc Interv. 2019;12:1067–76.

Article  PubMed  Google Scholar 

Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S, et al. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation. PLoS One. 2018;13:e0191592.

Article  PubMed  PubMed Central  Google Scholar 

Umeda H, Isotani A, Yano M, Tomiyama H, Shirai S, Ando K. Thrombus formation at the left ventricular apex due to split inflow after MitraClip implantation. JACC Cardiovasc Interv. 2019;12:e205–6.

Article  PubMed  Google Scholar 

Ismayl M, Ahmed H, Goldsweig AM, Freeman JV, Alkhouli M. In-hospital safety outcomes of left atrial appendage occlusion in octogenarians and nonagenarians. Europace. 2024;26:1–11.

Article  Google Scholar